Marco Marzioni

18.6k total citations · 3 hit papers
146 papers, 7.1k citations indexed

About

Marco Marzioni is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Marco Marzioni has authored 146 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Surgery, 81 papers in Hepatology and 46 papers in Oncology. Recurrent topics in Marco Marzioni's work include Pediatric Hepatobiliary Diseases and Treatments (59 papers), Liver physiology and pathology (45 papers) and Liver Disease Diagnosis and Treatment (36 papers). Marco Marzioni is often cited by papers focused on Pediatric Hepatobiliary Diseases and Treatments (59 papers), Liver physiology and pathology (45 papers) and Liver Disease Diagnosis and Treatment (36 papers). Marco Marzioni collaborates with scholars based in Italy, United States and Japan. Marco Marzioni's co-authors include Gianfranco Alpini, Shannon Glaser, A. Benedetti, Heather Francis, Domenico Alvaro, Pietro Invernizzi, Gianluca Svegliati‐Baroni, Christoph Schramm, Gideon M. Hirschfield and Ulrich Beuers and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Marco Marzioni

142 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

2017 886 citations Gideon M. Hirschfield, Pietro Invernizzi et al. Journal of Hepatology profile →
Wnt–β-catenin signalling in liver development, health and disease

2018 420 citations María J. Perugorria, Marco Marzioni et al. profile →
Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances

2018 265 citations Marco Marzioni, Fanyin Meng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Marzioni Italy	47	3.4k	3.2k	2.6k	1.6k	1.4k	146	7.1k
Guido Carpino Italy	45	2.2k 0.6×	2.8k 0.9×	1.8k 0.7×	1.3k 0.8×	1.1k 0.8×	140	5.6k
Domenico Alvaro Italy	61	4.2k 1.2×	5.9k 1.8×	2.3k 0.9×	2.1k 1.3×	2.9k 2.1×	258	10.5k
Antonio Franchitto Italy	44	2.2k 0.6×	2.3k 0.7×	1.5k 0.6×	975 0.6×	940 0.7×	133	4.9k
D. Montgomery Bissell United States	49	3.5k 1.0×	1.7k 0.5×	2.0k 0.8×	3.6k 2.3×	986 0.7×	101	8.5k
Jacquelyn J. Maher United States	40	2.9k 0.9×	1.3k 0.4×	3.2k 1.3×	2.0k 1.2×	715 0.5×	97	6.8k
Samuele De Minicis Italy	39	3.2k 0.9×	1.3k 0.4×	4.3k 1.7×	1.8k 1.2×	565 0.4×	57	7.1k
Verena Keitel Germany	40	1.5k 0.4×	2.2k 0.7×	1.7k 0.6×	1.2k 0.7×	2.9k 2.1×	166	5.5k
Ariane Mallat France	46	3.2k 0.9×	1.4k 0.4×	3.3k 1.3×	1.5k 0.9×	469 0.3×	123	7.5k
Gene LeSage United States	42	2.1k 0.6×	2.3k 0.7×	1.0k 0.4×	919 0.6×	1.5k 1.1×	84	4.6k
Yuzo Kodama Japan	28	903 0.3×	1.4k 0.4×	1.7k 0.6×	1.1k 0.7×	955 0.7×	195	4.5k

Countries citing papers authored by Marco Marzioni

Since Specialization

Citations

This map shows the geographic impact of Marco Marzioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Marzioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Marzioni more than expected).

Fields of papers citing papers by Marco Marzioni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Marzioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Marzioni. The network helps show where Marco Marzioni may publish in the future.

Co-authorship network of co-authors of Marco Marzioni

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Marzioni. A scholar is included among the top collaborators of Marco Marzioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Marzioni. Marco Marzioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Balducci, Daniele, Marco Valvano, A. Benedetti, et al.. (2024). The Impact of Radiofrequency Ablation on Survival Outcomes and Stent Patency in Patients with Unresectable Cholangiocarcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cancers. 16(7). 1372–1372. 2 indexed citations

Carbone, Marco, Alessio Gerussi, Vincenzo Cardinale, et al.. (2024). Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis. Digestive and Liver Disease. 56(9). 1461–1474. 5 indexed citations

Balducci, Daniele, et al.. (2023). Risk Stratification in Primary Biliary Cholangitis. Journal of Clinical Medicine. 12(17). 5713–5713. 3 indexed citations

Matteo, Sabina Di, Chiara Di Meo, Guido Carpino, et al.. (2022). Therapeutic effects of dexamethasone-loaded hyaluronan nanogels in the experimental cholestasis. Drug Delivery and Translational Research. 12(8). 1959–1973. 2 indexed citations

Kennedy, Lindsey, Heather Francis, Pietro Invernizzi, et al.. (2019). Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early‐stage primary biliary cholangitis. The FASEB Journal. 33(9). 10269–10279. 33 indexed citations

Aabakken, Lars, Tom H. Karlsen, Jörg Albert, et al.. (2017). Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Journal of Hepatology. 66(6). 1265–1281. 68 indexed citations

Burra, Patrizia, L Belli, Stefano Ginanni Corradini, et al.. (2017). Common issues in the management of patients in the waiting list and after liver transplantation. Digestive and Liver Disease. 49(3). 241–253. 18 indexed citations

Bernuzzi, Francesca, Francesco Marabita, Ana Lleò, et al.. (2016). Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. Clinical & Experimental Immunology. 185(1). 61–71. 70 indexed citations

Muñoz-Garrido, Patricia, María J. Perugorria, Oihane Erice, et al.. (2014). Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases. Gut. 63(10). 1658–1667. 36 indexed citations

10.

Minicis, Samuele De, C. Candelaresi, Laura Agostinelli, et al.. (2012). Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution. Liver International. 32(10). 1574–1584. 39 indexed citations

11.

Marzioni, Marco, S. Saccomanno, Laura Agostinelli, et al.. (2012). PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: Possible implications for sclerosing cholangitis. Journal of Hepatology. 58(4). 750–756. 22 indexed citations

12.

Minicis, Samuele De, Marco Marzioni, S. Saccomanno, et al.. (2011). Cellular and molecular mechanisms of hepatic fibrogenesis leading to liver cancer. 1(1). 88–94. 14 indexed citations

13.

Glaser, Shannon, Paolo Onori, Candace Wise, et al.. (2010). Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis. Digestive and Liver Disease. 42(4). 245–252. 27 indexed citations

14.

Alpini, Gianfranco, Pietro Invernizzi, Eugenio Gaudio, et al.. (2008). Serotonin Metabolism Is Dysregulated in Cholangiocarcinoma, which Has Implications for Tumor Growth. Cancer Research. 68(22). 9184–9193. 93 indexed citations

15.

Marzioni, Marco, Gianfranco Alpini, S. Saccomanno, et al.. (2007). Glucagon-Like Peptide-1 and Its Receptor Agonist Exendin-4 Modulate Cholangiocyte Adaptive Response to Cholestasis. Gastroenterology. 133(1). 244–255. 70 indexed citations

16.

Ueno, Yoshiyuki, Heather Francis, Shannon Glaser, et al.. (2007). Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway.. Università Politecnica delle Marche (Università Politecnica delle Marche). 232(7). 942–9. 15 indexed citations

17.

Alvaro, Domenico, Maria Grazia Mancino, Shannon Glaser, et al.. (2006). Proliferating Cholangiocytes: A Neuroendocrine Compartment in the Diseased Liver. Gastroenterology. 132(1). 415–431. 230 indexed citations

18.

Gaudio, Eugenio, Barbara Barbaro, Domenico Alvaro, et al.. (2006). Vascular Endothelial Growth Factor Stimulates Rat Cholangiocyte Proliferation Via an Autocrine Mechanism. Gastroenterology. 130(4). 1270–1282. 167 indexed citations

19.

Marzioni, Marco, Gianfranco Alpini, S. Saccomanno, et al.. (2006). Endogenous Opioids Modulate the Growth of the Biliary Tree in the Course of Cholestasis. Gastroenterology. 130(6). 1831–1847. 38 indexed citations

20.

Sario, A. Di, Gianluca Svegliati‐Baroni, Emanuele Bendia, et al.. (2001). Intracellular pH regulation and Na + /H + exchange activity in human hepatic stellate cells: effect of platelet-derived growth factor, insulin-like growth factor 1 and insulin. Journal of Hepatology. 34(3). 378–385. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact